通过生物信息学分析揭示系统性红斑狼和心力衰竭之间的共享生物标志物和治疗点
Ting Zhou1,2, Jing Pan2, Chenghui Yan2
1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in medicine
|June 24, 2024
概括
系统性红斑狼 (SLE) 和心力衰竭 (HF) 具有共同的机制,涉及免疫细胞透. HSP90AB1和UBC显示出作为同时发生的SLE和HF的治疗点的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
- 基因组学就是基因组学.
背景情况:
- 系统性红斑狼 (SLE) 与高死亡率的心血管疾病有关,特别是心力衰竭 (HF).
- 在SLE和HF之间共享的潜在机制仍然不完全理解.
- 确定共同的途径和治疗目标对于管理这些复杂的疾病至关重要.
研究的目的:
- 探索SLE和HF之间共同的分子机制.
- 确定SLE和HF的潜在共享治疗目标.
- 研究免疫细胞透在SLE和HF共同致病的作用.
主要方法:
- 来自NCBI GEO的SLE和HF数据集中的差异表达基因 (DEGs) 的分析.
- 基因本体学 (GO) 和基因和基因京都百科全书 (KEGG) 路径丰富分析.
- 蛋白与蛋白相互作用 (PPI) 网络构建和使用Cytoscape的枢纽基因识别.
- 使用R包"limma",用于免疫细胞透的CIBERSORT算法和权重基因共同表达网络分析 (WGCNA) 验证枢纽基因.
主要成果:
- 确定了999个共享的DEG,主要富含Th17细胞分化途径.
- 五个共享的枢纽基因 (HSP90AB1,NEDD8,RPLP0,UBB,UBC) 被确定并验证.
- 在失败的心脏中,HSP90AB1和UBC被上调,并与免疫细胞透介导的共同病原发生有关.
结论:
- HSP90AB1和UBC是SLE和HF共享病变发生的关键基因.
- 这些基因是SLE和HF的有希望的分子标记物.
- HSP90AB1和UBC代表了治疗SLE和HF患者的潜在治疗点.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
137
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K


